CoChat

Instillation of Sericin Enhances Corneal Wound Healing through the ERK Pathway in Rat Debrided Corneal Epithelium

Open access
Nagai, Noriaki, Fukuoka, Yuya, Ishii, Miyu, Otake, Hiroko, Yamamoto, Tetsushi, Taga, Atsushi, Okamoto, Norio, Shimomura, Yoshikazu · 2018 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Sericin is a major constituent of silk produced by silkworms. We previously found that the instillation of sericin enhanced the proliferation of corneal epithelial cells, and acted to promote corneal wound healing in both normal and diabetic model rats. However, the mechanisms by which sericin promotes the proliferation of corneal cells have not been established. In this study, we investigated the effects of sericin on Akt and ERK activation in a human corneal epithelial cell line (HCE-T cells) and rat debrided corneal epithelium. Although Akt phosphorylation was not detected following the treatment of HCE-T cells with sericin, ERK1/2 phosphorylation was enhanced. The growth of HCE-T cells treated with sericin was significantly increased, with the cell growth of sericin-treated HCE-T cells being 1.7-fold higher in comparison with vehicle-treated HCE-T cells. On the other hand, both of an ERK inhibitor U0126 (non-specific specific inhibitor) and SCH772984 (specific inhibitor) attenuated the enhanced cell growth by sericin, and the growth level in the case of co-treatment with sericin and ERK1/2 inhibitor was similar to that of cells treated with ERK1/2 inhibitor alone. In an in vivo study using rat debrided corneal epithelium, the corneal wound healing rate was enhanced by the instillation of sericin, and this enhancement was also attenuated by the instillation of U0126. In addition, the corneal wound healing rate in rats co-instilled with sericin and U0126 was similar to that following the instillation of U0126 alone. In conclusion, we found that the instillation of sericin enhanced cell proliferation via the activation of the MAPK/ERK pathway, resulting in the promotion of corneal wound healing in rat eyes. These findings provide significant information for designing further studies to develop potent corneal wound-healing drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms19041123

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Changes in Akt (A) and ERK1/2 (B) activation in human cornea epithelial cell line (HCE-T) cells treated with 0.01% sericin. Sericin was dissolved in saline. Samples were obtained 6 and 24 h after the addition of sericin. Sericin treatment enhanced the phosphorylation of ERK1/2.
Figure 1 Changes in Akt (A) and ERK1/2 (B) activation in human cornea epithelial cell line (HCE-T) cells treated with 0.01% sericin. Sericin was dissolved in saline. Samples were obtained 6 and 24 h after the addition of sericin. Sericin treatment enhanced the phosphorylation of ERK1/2.CC BY · PubMed Central
Figure 2 Effect of 0.01–0.2% sericin (A) and 0–20 μM U0126 (B) on the phosphorylation of ERK1/2 in HCE-T cells. (A) 0.01–0.2% sericin was dissolved in 0.05% DMSO, and treated for 24 h. (B) 0–20 μM U0126 was dissolved in 0.05% DMSO, and treated for 24 h. The phosphorylation of ERK1/2 was enhanced with the increase in sericin concentration; 20 μM U0126 prevented the phosphorylation of ERK1/2 in HCE-T cells.
Figure 2 Effect of 0.01–0.2% sericin (A) and 0–20 μM U0126 (B) on the phosphorylation of ERK1/2 in HCE-T cells. (A) 0.01–0.2% sericin was dissolved in 0.05% DMSO, and treated for 24 h. (B) 0–20 μM U0126 was dissolved in 0.05% DMSO, and treated for 24 h. The phosphorylation of ERK1/2 was enhanced with the increase in sericin concentration; 20 μM U0126 prevented the phosphorylation of ERK1/2 in HCE-T cells.CC BY · PubMed Central
Figure 3 Changes in JNK and p38 activation in HCE-T cells treated with 0.1% sericin. Sericin was dissolved in saline. Samples were obtained 24 h after the addition of saline (control) or sericin. Sericin treatment did not affect the phosphorylation of JNK and p38.
Figure 3 Changes in JNK and p38 activation in HCE-T cells treated with 0.1% sericin. Sericin was dissolved in saline. Samples were obtained 24 h after the addition of saline (control) or sericin. Sericin treatment did not affect the phosphorylation of JNK and p38.CC BY · PubMed Central
Figure 4 Effect of U0126 on the proliferation of HCE-T cells treated with sericin. Twenty micromoles of U0126, 0.5 μM SCH772984, and/or 0.1% sericin were dissolved in 0.05% DMSO, and treated for 24 h. Vehicle, 0.05% DMSO-treated HCE-T cells. U0126, U0126-treated HCE-T cells, SCH772984, SCH772984-treated HCE-T cells. Sericin, sericin-treated HCE-T cells. Sericin + U0126, sericin and U0126 co-treated treated HCE-T cells. Sericin + SCH772984, sericin and SCH772984 co-treated HCE-T cells. n = 7. *1 p < 0.05, vs. vehicle for each category. *2 p < 0.05, vs. U0126 for each category. *3 p < 0.05, vs. SCH772984 for each category. *4 p < 0.05, vs. sericin for each category. The enhanced growth in HCE-T cells treated with sericin was prevented by the addition of U126 and SCH772984.
Figure 4 Effect of U0126 on the proliferation of HCE-T cells treated with sericin. Twenty micromoles of U0126, 0.5 μM SCH772984, and/or 0.1% sericin were dissolved in 0.05% DMSO, and treated for 24 h. Vehicle, 0.05% DMSO-treated HCE-T cells. U0126, U0126-treated HCE-T cells, SCH772984, SCH772984-treated HCE-T cells. Sericin, sericin-treated HCE-T cells. Sericin + U0126, sericin and U0126 co-treated treated HCE-T cells. Sericin + SCH772984, sericin and SCH772984 co-treated HCE-T cells. n = 7. *1 p < 0.05, vs. vehicle for each category. *2 p < 0.05, vs. U0126 for each category. *3 p < 0.05, vs. SCH772984 for each category. *4 p < 0.05, vs. sericin for each category. The enhanced growth in HCE-T cells treated with sericin was prevented by the addition of U126 and SCH772984.CC BY · PubMed Central
Figure 5 Effect of sericin on ERK1/2 activation in rat debrided corneal epithelium. One percent sericin was dissolved in saline, and the saline (control) or sericin was instilled into the eyes of rats five times a day. The cornea was collected 24 h after corneal epithelial abrasion. The instillation of sericin enhanced the phosphorylation of ERK1/2 in the cornea of rats.
Figure 5 Effect of sericin on ERK1/2 activation in rat debrided corneal epithelium. One percent sericin was dissolved in saline, and the saline (control) or sericin was instilled into the eyes of rats five times a day. The cornea was collected 24 h after corneal epithelial abrasion. The instillation of sericin enhanced the phosphorylation of ERK1/2 in the cornea of rats.CC BY · PubMed Central
Figure 6 Corneal image (A) and corneal wound healing (B) in rat eyes treated with sericin and/or U0126. 1% sericin and 200 μM U0126 were dissolved in 0.2% DMSO, and instilled into the eyes of rats five times a day. The corneal images were obtained by a TRC-500X, and corneal wound healing was calculated according to Equation (2). Normal (○), non-instilled rat. vehicle (△), 0.2% DMSO-instilled rat. U0126 (□), U0126-instilled rat, sericin (▲), sericin-instilled rat. Sericin + U0126 (■), sericin-instilled rat treated with U0126. n = 5–8. *1 p < 0.05, vs. vehicle for each category. *2 p < 0.05, vs. U0126 for each category. *3 p < 0.05, vs. sericin for each category. The corneal wound healing was increased by the instillation of sericin, and the enhanced corneal wound healing in rats instilled with sericin was prevented by treatment with U0126.
Figure 6 Corneal image (A) and corneal wound healing (B) in rat eyes treated with sericin and/or U0126. 1% sericin and 200 μM U0126 were dissolved in 0.2% DMSO, and instilled into the eyes of rats five times a day. The corneal images were obtained by a TRC-500X, and corneal wound healing was calculated according to Equation (2). Normal (○), non-instilled rat. vehicle (△), 0.2% DMSO-instilled rat. U0126 (□), U0126-instilled rat, sericin (▲), sericin-instilled rat. Sericin + U0126 (■), sericin-instilled rat treated with U0126. n = 5–8. *1 p < 0.05, vs. vehicle for each category. *2 p < 0.05, vs. U0126 for each category. *3 p < 0.05, vs. sericin for each category. The corneal wound healing was increased by the instillation of sericin, and the enhanced corneal wound healing in rats instilled with sericin was prevented by treatment with U0126.CC BY · PubMed Central
Figure 7 Effects of continuous treatment with sericin on eyes in rabbits. The sustained-release hydrogel containing saline and/or sericin was injected into the conjunctiva (black circles) and maintained for 21 days. No abnormal changes, such as angiogenesis, were observed in the rabbit eyes 21 days after insertion of hydrogel containing sericin.
Figure 7 Effects of continuous treatment with sericin on eyes in rabbits. The sustained-release hydrogel containing saline and/or sericin was injected into the conjunctiva (black circles) and maintained for 21 days. No abnormal changes, such as angiogenesis, were observed in the rabbit eyes 21 days after insertion of hydrogel containing sericin.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 2

  1. Albert, D.M., and Jakobiec, F.A. (1994). Agents that Affect Corneal Wound Healing: Modulation of Structure and Function, Saunders Press.
  2. Azar, 2006, Corneal angiogenic privilege: Angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing, Trans. Am. Ophthalmol. Soc., 104, 264

Cited by

See all 37

Metadata

Authors
Nagai, N., Fukuoka, Y., Ishii, M., Otake, H., Yamamoto, T., Taga, A., Okamoto, N., & Shimomura, Y.
Affiliations
Kindai University (JP)
Corresponding author
Nagai, Noriaki
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2018-04-09
Volume
19
Issue
4
Pages
1123
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2797719508
Cited by
37
References
40
Citations by year
2026: 1 · 2025: 6 · 2024: 3 · 2023: 3 · 2022: 7 · 2021: 11 · 2020: 2 · 2019: 2 · 2018: 2
FWCI
2.93
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Ophthalmology › Corneal Surgery and Treatments
  • Physical Sciences › Materials Science › Biomaterials › Silk-based biomaterials and applications
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
Keywords
sericin, corneal wound healing, corneal epithelium, ERK signaling, MAPK/ERK pathway, cell proliferation, Akt, U0126, SCH772984, ocular drug delivery
MeSH terms
Animals, Cell Line, Disease Models, Animal, Humans, Instillation, Drug, Phosphorylation, Wound Healing, Epithelium, Corneal, MAP Kinase Signaling System, Sericins, Cell Proliferation, Rats, Corneal Injuries

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Instillation of Sericin Enhances Corneal Wound Healing through the ERK Pathway in Rat Debrided Corneal Epithelium. https://app.cochat.ai/papers/10.3390/ijms19041123
The paper
Nagai, N., Fukuoka, Y., Ishii, M., Otake, H., Yamamoto, T., Taga, A., Okamoto, N., & Shimomura, Y. (2018). Instillation of Sericin Enhances Corneal Wound Healing through the ERK Pathway in Rat Debrided Corneal Epithelium. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms19041123

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.